GoodRx Shares Soar 50% on Wall Street Debut
Rachel Uranga covers the intersection of business, technology and culture. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.
Prescription discount GoodRx shares skyrocketed more than 50% in its Wall Street debut on Wednesday. Shares started trading under the symbol "GDRX" at an IPO pricing of $33 each but quickly rose landing at $50.50 per share at market close.
GoodRx is the first Los Angeles tech company to go public this year and follows a wave of other tech companies that have recently gone public, including Unity and Snowflake.
Co-founded by former Facebook executive Doug Hirsch in 2011, the Santa Monica company makes money by collecting fees from pharmacy benefits managers.
The popular app provides comparison drug pricing at different pharmacies, breaking down what is often a murky market. Hirsch told dot.LA in an interview earlier this year that the idea came to him when, on a whim, he began comparing drug prices at local pharmacies and found pharmacists could not explain the difference.
Over recent years, GoodRx has boasted steady growth. The company earned $54 million in profit for the first six months ending in June, up from $31 million over the same time last year, a 74% increase. It has $697 million in debt as of June 30.
Last year, GoodRx expanded into telehealth with HeyDoctor. While patients have flocked to the new service during the pandemic, the division is less profitable than the prescription side of the business.
- GoodRx is looking to go public: Reuters - dot.LA ›
- GoodRx To Enter NASDAQ as GDRX - dot.LA ›
- GoodRx Files for IPO - dot.LA ›
- GOAT and GoodRx's Very Good Day - dot.LA ›
- GoodRx Shares Fall Despite Robust Revenue Growth - dot.LA ›
- GoodRx Stock Plummets After Amazon Announcement - dot.LA ›
Subscribe to our newsletter to catch every headline.
On a recent crisp winter morning outside an empty office park in the San Fernando Valley, there were no workers to be seen. That is unless one counts the cooler-sized delivery robot slowly whirring down the sidewalk as Felipe Chavez, founder and CEO of Kiwibot, nervously watched to make sure the droid did not veer of course.
Just as no one now thinks twice about seeing e-scooters that were non-existent before late 2017, the sight of a robot ferrying salads, pizza, or groceries could become common on Los Angeles sidewalks before this year is over.
Photo by Ben Bergman
- Amazon unveils its own smart grocery cart, in new effort to automate ... ›
- CVS and UPS Are Teaming Up For Drone Deliveries to Retirees ... ›
- Los Angeles Wants Drone Delivery by 2023 - dot.LA ›
On this week's episode of Office Hours, you'll hear from Steven Galanis, founder and CEO of Cameo, which offers a marketplace of celebrities that will record a custom-crafted message for a fee.
- Watch: Our Virtual Fireside Chat with Cameo Founder and CEO ... ›
- Office Hours Podcast: Bill Gurley On Startups, Venture Capital and ... ›
- Cameo's CEO On How He Plans to Disrupt Hollywood - dot.LA ›